Genomics & Genetics Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Genomics & Genetics Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Business Update
Stem Cell Sciences cites two published reports validating proprietary cloning technologies
July 14th, 2006
Stem Cell Sciences plc (SCS), the first scientific team to prove therapeutic cloning is possible in mammalian species, acknowledged two reports by academic scientists from the University of Edinburgh and Massachusetts Institute of Technology (MIT) that validate proprietary SCS technologies for improving the efficiency of therapeutic cloning, or so-called "cell reprogramming." In a significant report, published in the journal Nature, Austin Smith and colleagues at the University of Edinburgh conclusively demonstrate that the candidate pluripotency gene "Nanog," named after Tir nan Og, the mythological Celtic land of the ever young, can indeed play a dominant role...
Source: Genomics & Genetics Weekly (2006-07-14)
|
